SCHEMBL28787804

SCHEMBL28787804

CN(C)c1ccncc1.N=C=O

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM5 P08912 1/20 0.73
CHKA P35790 1/20 0.73
MAPT P10636 5/20 0.56
SMN1; SMN2 Q16637 3/20 0.56
KMT2A Q03164 3/20 0.50
ALOX15 P16050 2/20 0.50
MEN1 O00255 2/20 0.50
NPC1 O15118 1/20 0.50
CASP1 P29466 1/20 0.50
RAB9A P51151 1/20 0.50
HBB P68871 1/20 0.50
ALDH1A1 P00352 7/20 0.43
TSHR P16473 3/20 0.43
HSD17B10 Q99714 2/20 0.43
KDM4E B2RXH2 4/20 0.39
GFER P55789 1/20 0.39
MPO P05164 1/20 0.38
TP53 P04637 1/20 0.37
MAPK1 P28482 1/20 0.37
HIF1A Q16665 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Carbimide SCHEMBL28028271 0.91 CHRM5 (0.80) CHRM5CHKAMAPTSMN1; SMN2KMT2A
SCHEMBL189 0.85
SCHEMBL8664726 0.85 CHRM5 (1.00) CHRM5CHKAMAPTSMN1; SMN2KMT2A
Formaldehyde SCHEMBL27435490 0.83 CHRM5 (0.84) CHRM5CHKAMAPTSMN1; SMN2KMT2A
Phosphine SCHEMBL23270013 0.83 CHRM5 (0.94) CHRM5CHKAMAPTSMN1; SMN2KMT2A
Bromide SCHEMBL393565 0.83 CHRM5 (0.94) CHRM5CHKAMAPTSMN1; SMN2KMT2A
Bromide SCHEMBL393564 0.83 CHRM5 (0.94) CHRM5CHKAMAPTSMN1; SMN2KMT2A
SCHEMBL4405649 0.83 CHRM5 (0.94) CHRM5CHKAMAPTSMN1; SMN2KMT2A
Bromide SCHEMBL1542160 0.83 CHRM5 (0.94) CHRM5CHKAMAPTSMN1; SMN2KMT2A
SCHEMBL2277093 0.83 CHRM5 (0.94) CHRM5CHKAMAPTSMN1; SMN2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102089289-A Novel heterocyclyl compounds for treatment of cardiovascular disease HOFFMANN LA ROCHE 2011-06-08 CN disclosed